Sayana Press (DMPA-SC in Uniject) Clinical Brief

This brief provides a clinical overview of the injectable contraceptive subcutaneous DMPA (DMPA-SC or Sayana® Press), which contains 30% less depot medroxyprogesterone acetate than the intramuscular presentation of Depo-Provera®. DMPA-SC is administered subcutaneously through the prefilled Uniject injection system, an autodisable injection device. For more information, visit www.path.org/dmpa-sc, sign up for our newsletter, or email FPoptions@path.org.

Corporate author(s): PATH

Publication date: March 2017

Available materials

  1. English

    1. Sayana Press (DMPA-SC in Uniject) Clinical Brief - PDF

  2. French

    1. Sayana Press (DMPA-SC in Uniject) Clinical Brief [French] - PDF